New Study Investigates Advanced Glucose Monitoring for Hospitalized Hyperglycemia

Hyperglycemia (high blood sugar) is a common and serious complication for hospitalized patients, particularly those with Type 2 diabetes, often leading to increased inflammation and poorer outcomes. While effective glucose management is crucial, conventional monitoring methods can be suboptimal in achieving tight control and mitigating inflammatory responses. This Phase 4 study aims to evaluate if advanced continuous glucose monitoring (CGM) combined with specific insulin protocols can improve inflammatory markers and glucose control in this vulnerable population.

As an ongoing Phase 4 clinical trial, specific results regarding the effects of glucose control and monitoring on inflammation are not yet available. The study is designed to assess whether different insulin protocols and glucose monitoring systems can lead to improved outcomes in hospitalized patients with hyperglycemia. Researchers will be collecting data on inflammatory markers and glucose levels across the different treatment arms. > The primary aim is to determine if the insulin protocol with continuous glucose monitoring (CGM) can demonstrate superior control and anti-inflammatory effects compared to conventional approaches. It is anticipated that the CGM-guided group will show more precise glucose management and a beneficial impact on inflammatory responses, potentially leading to reduced hospital stays and fewer complications.